Continuing on its mission to curb abusive collection efforts related to medical debt which began to take life in 2022, the CFPB on Sept. 21 announced its initiation of a rulemaking process to remove medical bills from credit reports entirely.
Motivated by “research” which the CFPB identifies as showing that “medical bills have little predictive value in credit decisions” the agency outlined several proposals under consideration “that would help families financially recover from medical crises, stop debt collectors from coercing people into paying bills they may not even owe, and ensure that creditors are not relying on data that is often plagued with inaccuracies and mistakes.”
Under consideration for the CFPB’s rulemaking are the following proposals:
Remove medical bills from consumers’ credit reports:
- Consumer reporting companies would be prohibited from including medical debts and collection information on consumer reports that creditors use in making underwriting decisions.
Stop creditors from relying on medical bills for underwriting decisions:
- The proposal would narrow the 2005 exception[1] and prohibit creditors from using medical collections information when evaluating borrowers’ credit applications.
Stop coercive collection practices:
- As unpaid medical bills would no longer appear on consumers’ credit reports used by creditors in making underwriting decisions, debt collectors would no longer be able to use the credit reporting system as leverage to pressure consumers into paying questionable debts.
Importantly, the CFPB notes, the proposals would not prohibit creditors from obtaining medical billing information for other purposes, such as evaluating loan applications intended to fund medical services and for determining if a consumer qualifies for medical forbearance programs available.
The proposed rulemaking comes on the tails of the CFPB identifying medical debt, and specifically its credit reporting, as a priority beginning in 2022. Specifically, and as a refresher, early 2022 saw the CFPB issue its bulletin regarding the collection and credit reporting of medical debt which concluded that medical debt posed a “special risk” to consumers because medical debt is typically an unanticipated indebtedness, consumers are not always advised of the costs of medical services in advance, there is no real “marketplace” for medical services where consumers can shop around for the best value, and there exists a lack of education among consumers regarding the insurance process and how to identify potential billing errors.
Next, in March of 2022, the CFPB issued its “official report” regarding the burden on consumers created by medical debt. The report’s key findings were that there was approximately $88 billion in medical debt reflected on consumer credit records as of June 2021 with most of the related tradelines being $500 or less and that 58% of all consumer tradelines as of 2021 were medical debt. The CFPB concluded that the current practices related to the collections and credit reporting of medical debt can cause “significant harm” to consumers.
Relatedly, also in March of 2022, the CRAs responded to the CFPB’s official report, by identifying certain consumer-conscious changes they were implementing. Specifically, beginning July 1, 2022, defaulted medical debt placed for collections and which had subsequently been paid no longer appears on a consumer credit report, and defaulted medical debt is not reported until one year after default. Beginning March 30, 2023, the CRAs also ceased placing medical debts with furnished balances below $500 on a consumer report.
Given the CFPB’s posture towards medical debt and its presence on consumer credit reports, the proposed rulemaking is simply the culmination of its efforts to limit the impact of medical debt on consumers while also limiting available remedies for industry members who work with medical debt. The frustration for the industry most certainly lies with the CFPB’s repeated labeling of medical debt as “questionable” and “inaccurate,” although failing to present data to support these claims save for reliance upon consumer complaints received and summarized in the CFPB’s complaint bulletin in April of 2022 which concluded that the nature of the consumer complaints being received in relation to medical debt “strongly suggest that many medical bills reported on credit reports are disputed, inaccurate, or not owed.”
Regardless of whether some or all the proposals ultimately result in rulemaking, the accuracy and propriety of medical debt balances being collected upon will continue to face heightened scrutiny from state and federal regulators.
As we progress towards the end of 2023 and into 2024, the attorneys at Maurice Wutscher LLP will continue to monitor and provide updates on all developments in the medical debt space.
[1] The Fair Credit Reporting Act restricts creditors’ ability to use medical information in making credit decisions and places limits on the inclusion of medical information on credit reports. The FCRA granted financial regulators authority to create regulatory exemptions to this restriction. In 2005, exception was created to allow creditors to rely on medical data if it could be characterized as “financial information.”
Photo: eurobanks – stock.adobe.com
